Literature DB >> 479375

Neutrophil-binding immunoglobulin G in systemic lupus erythematosus.

G Starkebaum, W P Arend.   

Abstract

The objectives of these studies were to quantify the amounts of immunoglobulin (Ig)G bound to peripheral blood neutrophils from patients with systemic lupus erythematosus (SLE) and to determine the contributions of soluble immune complexes or anticell antibodies to the levels of IgG neutrophil-binding activity in SLE sera. Neutrophil-bound IgG, determined by a sensitive antiglobulin inhibition assay, was elevated in 7 out of 14 SLE patients compared with values obtained in 23 normal controls. The levels of IgG neutrophil-binding activity in sera were elevated in 22 of 38 patients with SLE over the values seen with 36 normal sera. No correlation was found between the peripheral blood neutrophil counts in the SLE patients and the values for IgG adherent to the cells or serum cell-binding activity. The sera from 18 patients with SLE were fractionated by gel filtration. Elevated levels of IgG neutrophil-binding activity were found in 11 of the 18 G-200 excluded pools and in 13 of the G-200 IgG pools. In nine sera elevated levels were observed in both pools. F(ab')2 fragments of IgG from SLE sera bound to normal polymorphonuclear leukocytes in greater amounts than F(ab')2 fragments of IgG from normal sera. A significant correlation existed between the values of IgG neutrophil-binding activity found in SLE sera and those obtained with both the G-200 excluded and IgG pools. Sucrose density gradient fractionation of four sera from SLE patients confirmed the presence of both large (greater than 19S) and intermediate-sized (7S-19S) cell-binding immune complexes as well as of monomeric IgG antibodies to neutrophils. The levels of IgG neutrophil-binding activity in the SLE sera correlated well with the results obtained with the Raji cell assay for immune complexes as well as with the titer of antibodies to nuclear antigens. These data indicate that circulating neutrophils from patients with SLE commonly have increased amounts of cell-bound IGG. The elevated levels of IgG neutrophil-binding activity in the sera of these patients are caused by both soluble immune complexes and antibodies reactive with neutrophils.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 479375      PMCID: PMC372198          DOI: 10.1172/JCI109556

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  33 in total

1.  Study of leukopenias and thrombocytopenias by the direct antiglobulin consumption test on leukocytes and/or platelets.

Authors:  J DAUSSET; J COLOMBANI; M COLOMBANI
Journal:  Blood       Date:  1961-12       Impact factor: 22.113

2.  Structural units of human 7S gamma globulin.

Authors:  E C FRANKLIN
Journal:  J Clin Invest       Date:  1960-12       Impact factor: 14.808

3.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

4.  The hematologic aspects of disseminated (systemic) lupus erythematosus.

Authors:  S R MICHAEL; I L VURAL; F A BASSEN; L SCHAEFER
Journal:  Blood       Date:  1951-11       Impact factor: 22.113

5.  Certain polyclonal antinuclear antibodies cross-react with the surface membrane of human lymphocytes and granulocytes.

Authors:  O P Rekvig; K Hannestad
Journal:  Scand J Immunol       Date:  1977       Impact factor: 3.487

6.  Anti-beta2-microglobulin lymphocytotoxic autoantibodies in systemic lupus erythematosus.

Authors:  J P Revillard; C Vincent; S Rivera
Journal:  J Immunol       Date:  1979-02       Impact factor: 5.422

7.  Binding of affinity cross-linked oligomers of IgG to cells bearing Fc receptors.

Authors:  D M Segal; E Hurwitz
Journal:  J Immunol       Date:  1977-04       Impact factor: 5.422

8.  Autoantibody against B lymphocytes.

Authors:  M S Park; P I Terasaki; D Bernoco
Journal:  Lancet       Date:  1977-09-03       Impact factor: 79.321

9.  Neoantigen of the membrane attack complex of human complement: Occurrence on peripheral blood leukocytes from patients with systemic lupus erythematosus.

Authors:  J G Curd; J S Sundsmo; W P Kolb; H G Bluestein; H J Müller-Eberhard
Journal:  Arthritis Rheum       Date:  1978-03
View more
  10 in total

1.  Chlorthalidone-associated neutropenia.

Authors:  S T Writer; D L Stevens; G Starkebaum
Journal:  West J Med       Date:  1982-01

2.  Association of neutropenia in systemic lupus erythematosus (SLE) with anti-Ro and binding of an immunologically cross-reactive neutrophil membrane antigen.

Authors:  B T Kurien; J Newland; C Paczkowski; K L Moore; R H Scofield
Journal:  Clin Exp Immunol       Date:  2000-04       Impact factor: 4.330

3.  Anti-SSB/La is one of the antineutrophil autoantibodies responsible for neutropenia and functional impairment of polymorphonuclear neutrophils in patients with systemic lupus erythematosus.

Authors:  S-C Hsieh; H-S Yu; W-W Lin; K-H Sun; C-Y Tsai; D-F Huang; Y-Y Tsai; C-L Yu
Journal:  Clin Exp Immunol       Date:  2003-03       Impact factor: 4.330

4.  Presence of antibodies to SSB/La is associated with decreased phagocytic efficiency of neutrophils in patients with systemic lupus erythematosus.

Authors:  Debasis Biswas; Amrita Mathias; Rajeshwar Dayal; Amita Aggarwal; Ramnath Misra; Sita Naik
Journal:  Clin Rheumatol       Date:  2007-11-06       Impact factor: 2.980

5.  Circulating colony-forming units of granulocytes and monocytes/macrophages in systemic lupus erythematosus.

Authors:  X López-Karpovitch; M Cardiel; R Cardenas; J Piedras; D Alarcón-Segovia
Journal:  Clin Exp Immunol       Date:  1989-07       Impact factor: 4.330

6.  Human alveolar macrophage cytophilic immunoglobulin G-mediated phagocytosis of protein A-positive staphylococci.

Authors:  H A Verbrugh; J R Hoidal; B Y Nguyen; J Verhoef; P G Quie; P K Peterson
Journal:  J Clin Invest       Date:  1982-01       Impact factor: 14.808

7.  Some characteristics of neutrophils from diabetic patients and their relation to the levels of circulating immune complexes.

Authors:  R I Barañao; L S Rumi; P A Tesone; V G Foglia
Journal:  Acta Diabetol Lat       Date:  1988 Jan-Mar

Review 8. 

Authors:  C Kneitz; J Atta; H Burkhardt
Journal:  Z Rheumatol       Date:  2017-10       Impact factor: 1.372

Review 9.  Primary and secondary autoimmune neutropenia.

Authors:  Franco Capsoni; Piercarlo Sarzi-Puttini; Alberto Zanella
Journal:  Arthritis Res Ther       Date:  2005-08-31       Impact factor: 5.156

10.  Neutrophil FcγRIIA availability is associated with disease activity in systemic lupus erythematosus.

Authors:  Anders A Bengtsson; Helena Tyden; Christian Lood
Journal:  Arthritis Res Ther       Date:  2020-05-29       Impact factor: 5.156

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.